title: Rapid insulin-mediated increase in microvascular glycocalyx accessibility in skeletal muscle may contribute to insulin-mediated glucose disposal in rats.
abstract: It has been demonstrated that insulin-mediated recruitment of microvascular blood volume is associated with insulin sensitivity. We hypothesize that insulin rapidly stimulates penetration of red blood cells (RBC) and plasma into the glycocalyx and thereby promotes insulin-mediated glucose uptake by increasing intracapillary blood volume. Experiments were performed in rats; the role of the glycocalyx was assessed by enzymatic degradation using a bolus of hyaluronidase. First, the effect of insulin on glycocalyx accessibility was assessed by measuring the depth of penetration of RBCs into the glycocalyx in microvessels of the gastrocnemius muscle with Sidestream Dark-field imaging. Secondly, peripheral insulin sensitivity was determined using intravenous insulin tolerance tests (IVITT). In addition, in a smaller set of experiments, intravital microscopy of capillary hemodynamics in cremaster muscle and histological analysis of the distribution of fluorescently labeled 40 kDa dextrans (D40) in hindlimb muscle was used to evaluate insulin-mediated increases in capillary blood volume. Insulin increased glycocalyx penetration of RBCs by 0.34±0.44 µm (P<0.05) within 10 minutes, and this effect of insulin was greatly impaired in hyaluronidase treated rats. Further, hyaluronidase treated rats showed a 35±25% reduction in whole-body insulin-mediated glucose disposal compared to control rats. Insulin-mediated increases in capillary blood volume were reflected by a rapid increase in capillary tube hematocrit from 21.1±10.1% to 29.0±9.8% (P<0.05), and an increase in D40 intensity in individual capillaries of 134±138% compared to baseline at the end of the IVITT. These effects of insulin were virtually abolished in hyaluronidase treated animals. In conclusion, insulin rapidly increases glycocalyx accessibility for circulating blood in muscle, and this is associated with an increased blood volume in individual capillaries. Hyaluronidase treatment of the glycocalyx abolishes the effects of insulin on capillary blood volume and impairs insulin-mediated glucose disposal.
authors: Department of Physiology, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, The Netherlands. B.Eskens@maastrichtuniversity.nl
authors: Bart J M
authors: BJ
authors: Eskens
authors: Hans L
authors: HL
authors: Mooij
authors: Jack P M
authors: JP
authors: Cleutjens
authors: Jozef M A
authors: JM
authors: Roos
authors: Johanna E
authors: JE
authors: Cobelens
authors: Hans
authors: H
authors: Vink
authors: Jurgen W G E
authors: JW
authors: Vanteeffelen
mesh_terms: D000704:Analysis of Variance; D000818:Animals; D001810:Blood Volume / Q000187:drug effects / Q000502:physiology; D004912:Erythrocytes / Q000502:physiology; D005947:Glucose / Q000378:metabolism*; D019276:Glycocalyx / Q000378:metabolism*; D006400:Hematocrit; D006652:Histological Techniques; D006821:Hyaluronoglucosaminidase / Q000494:pharmacology; D007328:Insulin / Q000378:metabolism*; D007329:Insulin Antagonists / Q000494:pharmacology; D007333:Insulin Resistance / Q000502:physiology; D008297:Male; D055806:Microvessels / Q000378:metabolism*; D018482:Muscle, Skeletal / Q000098:blood supply* / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar
chemical_list: D007328:Insulin; D007329:Insulin Antagonists; D006821:Hyaluronoglucosaminidase; D005947:Glucose
references: J Appl Physiol (1985). 2007 Jun;102(6):2251-9
references: 17347383
references: Diabetes. 2006 Apr;55(4):1127-32
references: 16567538
references: Diabetologia. 2009 May;52(5):752-64
references: 19283361
references: Am J Physiol. 1979 Oct;237(4):H481-90
references: 495734
references: Microvasc Res. 2002 Jul;64(1):38-46
references: 12074629
references: Cardiovasc Res. 2010 Jul 15;87(2):311-9
references: 20418474
references: Diabetes Metab Res Rev. 2004 Jan-Feb;20(1):3-12
references: 14737741
references: Hypertension. 2007 Jul;50(1):261-7
references: 17452501
references: Am J Physiol Endocrinol Metab. 2004 Oct;287(4):E804-9
references: 15213062
references: Am J Physiol. 1982 Dec;243(6):H1018-26
references: 7149038
references: Am J Physiol Heart Circ Physiol. 2007 Sep;293(3):H1526-35
references: 17526647
references: J Appl Physiol (1985). 2008 Mar;104(3):889-91
references: 17656624
references: Diabetes. 2007 Dec;56(12):2958-63
references: 17720897
references: Am J Physiol. 1990 Mar;258(3 Pt 2):H647-54
references: 2316679
references: Pflugers Arch. 2007 Jun;454(3):345-59
references: 17256154
references: Annu Rev Biochem. 1999;68:729-77
references: 10872465
references: Am J Physiol Heart Circ Physiol. 2005 Jul;289(1):H447-54
references: 15734874
references: Curr Opin Lipidol. 2005 Oct;16(5):507-11
references: 16148534
references: Am J Physiol Heart Circ Physiol. 2010 Feb;298(2):H515-23
references: 19940074
references: J Appl Physiol (1985). 2005 Oct;99(4):1471-6
references: 16024521
references: Clin Exp Pharmacol Physiol. 2005 Apr;32(4):302-7
references: 15810996
references: Lab Anim. 1981 Apr;15(2):111-7
references: 7278110
references: Biorheology. 2009;46(3):181-9
references: 19581726
references: Circ Res. 2003 Apr 4;92(6):592-4
references: 12637366
references: Diabetes. 2004 Feb;53(2):447-53
references: 14747297
references: Microcirculation. 2012 Aug;19(6):494-500
references: 22360160
references: Am J Physiol Endocrinol Metab. 2011 Aug;301(2):E252-63
references: 21610226
references: Trends Cardiovasc Med. 2007 Apr;17(3):101-5
references: 17418372
references: Diabetes. 2004 Jun;53(6):1418-23
references: 15161743
references: Crit Care. 2005;9 Suppl 4:S13-9
references: 16168069
references: Circ Res. 1996 Sep;79(3):581-9
references: 8781491
references: J Clin Endocrinol Metab. 2003 Apr;88(4):1610-6
references: 12679446
references: Proc Natl Acad Sci U S A. 1975 Sep;72(9):3526-30
references: 171664
references: Am J Physiol. 1996 Dec;271(6 Pt 1):E1067-72
references: 8997227
references: J Clin Endocrinol Metab. 2003 Oct;88(10):4559-64
references: 14557422
references: Am J Physiol. 1999 Aug;277(2):H508-14
references: 10444475
references: Diabet Med. 1992 Jun;9(5):432-7
references: 1611830
references: Arterioscler Thromb Vasc Biol. 2003 Sep 1;23(9):1541-7
references: 12855481
references: Am J Physiol Heart Circ Physiol. 2010 Jun;298(6):H1870-8
references: 20348228
references: Curr Opin Clin Nutr Metab Care. 2007 Jul;10(4):523-30
references: 17563474
references: Endocr Rev. 2007 Aug;28(5):463-91
references: 17525361
references: J Physiol. 2008 Jul 1;586(13):3207-18
references: 18450777
references: Dig Dis Sci. 2009 Dec;54(12):2706-11
references: 19117129
references: Eur J Clin Invest. 2003 Feb;33(2):141-6
references: 12588288
references: Eur J Appl Physiol Occup Physiol. 1999 Oct;80(5):461-6
references: 10502080
references: Am J Physiol. 1987 Mar;252(3 Pt 2):H494-503
references: 3548438
references: Clin Hemorheol Microcirc. 2010;44(3):217-25
references: 20364067
references: J Intern Med. 2006 Apr;259(4):339-50
references: 16594902
references: Diabetes. 2002 Apr;51(4):1138-45
references: 11916937
references: Opt Express. 2007 Nov 12;15(23):15101-14
references: 19550794
references: J Am Soc Nephrol. 2012 Nov;23(11):1900-8
references: 23085635
references: Diabetologia. 2010 Dec;53(12):2646-55
references: 20865240
references: Am J Physiol Endocrinol Metab. 2008 Oct;295(4):E732-50
references: 18612041
references: Diabetes. 2008 Apr;57(4):828-35
references: 18223011
references: J Clin Invest. 1989 Nov;84(5):1620-8
references: 2681272
references: Am J Physiol Heart Circ Physiol. 2000 Jan;278(1):H285-9
references: 10644610
references: Am J Physiol Heart Circ Physiol. 2001 Mar;280(3):H1051-7
references: 11179046